Doktor sila henti ambil
hadiah syarikat ubat
Doctors, please Stop Taking Pharma
Gifts
It is wrong for
physicians and their staff to accept trips, meals, or gifts from pharmaceutical
companies. Pro or con?
During
the past 10 to 20 years, there has been a growing intrusion of pharmaceutical
companies and medical device makers into the day-to-day practice of medicine.
Industry gifts—pads, pens, logo bags, and the like—have grown commonplace. In
many doctors’ offices, hospitals, and medical centers, the free lunch, courtesy
of industry sponsors, has turned into an accepted way of life. And these gifts
can also include dinners at expensive restaurants (to hear a lecture by a
physician also being compensated by industry) or free travel to meetings at
fancy resorts (to participate in a medical education event sponsored by
industry).
That
is not to say I don’t value our relationships with the pharmaceutical industry.
Indeed, we depend on our industry partners to carry the fruits of our research
to market. At the same time, data increasingly show that even small gifts
influence the drugs physicians prescribe. On a larger scale, physicians who
serve as paid consultants to industry are more likely to recommend the approval
of a drug or device to the FDA than those not receiving consulting fees.
In
2005, I appointed a faculty task force to develop a policy on how Stanford
should ensure that our relationships with industry are ethical and appropriate.
In October, 2006, we enacted a policy across the Stanford University Medical
Center campus, prohibiting our faculty members from accepting gifts of any
kind, however small, anywhere on the medical campus or at off-site facilities
where they may practice.
It
also bars industry sales and marketing representatives from wandering the
hallways of our two hospitals and our laboratories, and prevents companies from
directly paying for meals in connection with educational programs—once a fairly
common practice. It requires that those involved in the decision to buy
formulary drugs or clinical equipment disclose any related financial interests.
We
are also developing guidelines for physician participation in “speakers
bureaus,” which offer generous honoraria from companies for taking part in
presentations related to company products.
Since
our policy went into effect, many other academic medical centers have followed
suit. As we train the next generation of physicians under these new standards,
we will sow the seed for what could be a wholesale cultural change in the U.S.
medical profession.
CON: YES, BUT
WITH CONDITIONS
U.S.
physicians are committed to quality health care. It’s part of the oath they
take. So, despite what critics say, it’s insulting to suggest that doctors
would prescribe treatments based on who gave them a slice of pizza, a pen, or a
medical dictionary. What’s more, there are regulations and a comprehensive
industry ethics code to help make sure information about new treatments
provided by America’s pharmaceutical research companies is accurate and
well-substantiated.
Existing
federal law is very clear: Pharmaceutical research companies and their
technically trained representatives, including some health-care professionals,
must not give physicians anything of value in exchange for the doctors writing
prescriptions for their medicines. The companies must also ensure that
information they convey to physicians is consistent with pharmaceutical product
labeling approved by the Food & Drug Administration. The fact is, federal
and state authorities, including the FDA, the Justice Dept., and state
Attorneys General are closely monitoring for improper activities.
For
its part, the Pharmaceutical Research & Manufacturers of America (PhRMA)
sponsors ethical guidelines to keep communications between its member companies
and physicians focused on proper use of medicines and the needs of patients.
The PhRMA ethics code says all forms of entertainment are inappropriate and
only modest meals—such as sandwiches—should be provided when doctors meet with
pharmaceutical research companies. Additionally, our code says items given to
physicians should not exceed $100 in value and should be things, including
stethoscopes and medical dictionaries, that benefit patients or support a
medical practice.
In
the end, it’s clear pharmaceutical research companies have the most extensive
information about new medicines. After all, they devote 10 to 15 years and
spend nearly $1 billion to develop just one new medicine in a process that
generates thousands of pages of scientific data.
To
us, the evidence is compelling: Physicians meeting with well-trained company
representatives gain crucial knowledge about side-effect profiles and proper
use of medicines. And when doctors are given free pharmaceutical samples, they
receive valuable firsthand experience that helps them decide which medications
to prescribe. The simple fact is company representatives help physicians
provide effective patient care. And that often saves lives.
Opinions and conclusions expressed in the BusinessWeek.com
Debate Room do not necessarily reflect the views ofBusinessWeek, BusinessWeek.com, or The
McGraw-Hill Companies.
random
February 12, 2008 2:31 PM
"U.S. physicians are committed to
quality health care. It's part of the oath they take. So, despite what critics
say, it's insulting to suggest that doctors would prescribe treatments based on
who gave them a slice of pizza, a pen, or a medical dictionary."
It may be insulting, but
the truth is often unkind. One of the first things a marketer learns in
business school is that by giving people freebies, these people will develop a
positive response to your brand name and logo. In psychology, this concept is
known as emotional equilibrium. If I do something nice for you, you will want
to do something nice for me in return. It's an evolutionary drive present in
social mammals like us. It builds social standing and allows the community to
stay stable and orderly.
So
we can angrily demand to know "how dare someone accuse doctors of being
influenced by promotional freebies?!" but that doesn't negate the fact
that doctors are human and the rules of evolution and social interaction apply
to them too.
NISHIKANT
February 13, 2008
9:06 AM
A
good debate but with no solution. Doctors are human, too, and greed for these
freebies applies to them as to any one of us. Moral values are rising, so maybe
the conscience of the doctors will govern the issue. Pharma companies are there
to make a profit, so whatever it takes to lure doctors, they will do.
RXone
February 13, 2008
7:05 PM
To
those who support the con perspective, I must respectfully ask you to remove
the wool from your eyes. I have been in this industry for 20 years. I have seen
many instances where marketing trumped science, and physicians were influenced
to prescribe. PhRMA may sponsor ethical guidelines; however, they are left
mostly to the physicians and others being "detailed" to enforce.
There are many ethical physicians who remain true to their science roots. I
suspect this is the minority.
Nina Chamness-Aguirre
February 13, 2008 9:13 PM
The
medical boards of each state should include as part of their ethics statements
that doctors cannot accept any gifts or freebies of any kind from drug-company
or medical-device representatives. Access to information about drugs and
innovative machines should be available to doctors and the public at
conferences and in medical journals--but not through marketing or sales
campaigns.
longnt
February 14, 2008
5:46 AM
It
is not wrong or right for physicians to accept these freebies. It is their
actions after receiving gifts. Pharmaceutical companies, like ones in other
industries, have to advertise their products in the most effective way. Their
target is doctors, not ordinary people, who have no right to choice what drugs
to use. If we look at the percentage of their spending on advertisements, it
may be much lower than in other sectors. Imagine that a marketer visits a
doctor for whom time is money. He may refuse to accept. Do you want to spend
your precious time for nothing? The drug catalog dropped on his desk will surely
be thrown into the bin.
If
companies' products cannot sell, they will go bankrupt. No one will do research
to produce drugs to cure our diseases. All of us could die prematurely.
lee
February 14, 2008
6:39 AM
Pro,
con, that's the issue? The issue is how pharma makes nothing that works and
sucks the money out of people. Pharma, tobacco, alcohol, and sugary foods,
crap. All crap.
Dr. M Johnson
February 14, 2008
8:29 AM
If
the freebies didn't influence physicians, would intelligent, sophisticated
companies with access to the most advanced marketing research in the world
spend so much money on them, year after year after year?
If
the freebies don't influence physicians, why do pharma companies resist banning
them?
Greg Kelly
February 14, 2008
10:54 AM
The
bottom line is, are America's physicians to be trusted to do the right thing?
History shows the vast majority of doctors always put the interests of their
patients (and by extension their professional reputations) before any gift they
get from drug companies.
And
national polls consistently show that the vast majority of Americans (in the
90% range) trust doctors to give them unbiased advice. Let's leave it at that.
Greg Kelly
Editor
Physicians' Financial News
Editor
Physicians' Financial News
Robert Laughing
February 14, 2008 11:49 AM
Free?
Nothing from Big Pharma is "free." Everyone pays 10 times over for
these trinkets and baubles. They also need the money to ensure Congress permits
them every method of marketing and pricing abuse, and should their actions
become so uproariously outrageous, our government "fines" them a few
pieces of silver. And that just goes to Congress to spend, spend, spend. I'm
voting against every incumbent come November. It is the only way.
Roger McNamee
February 14, 2008
4:43 PM
Mr.
Kelly, editor of Physician's Financial News, claims, "History shows the
vast majority of doctors always put the interests of their patients...before
any gift they get from drug companies."
I
just searched the most likely databases of publications and found no data and
no historical work that demonstrate that the vast majority, a slim majority, or
any proportion of doctors always put the interests of their patients before
gifts from drug companies.
As
an editor, Mr. Kelly would not make a claim that is totally unsubstantiated.
Perhaps he could provide a citation for the claim that history shows it.
RXone
February 14, 2008
7:22 PM
I
agree with Greg Kelly to the extent that "the vast majority of doctors
always put the interests of their patients (and by extension their professional
reputations) before any gift they get from drug companies." The crux of
the issue as I see it is this: Physicians may prescribe a medication that is
indeed in the best interest of his/her patient from a medical perspective. I
believe it is incumbent upon physicians to be good stewards of our resources as
well. This is not to say they should prescribe medications with inferior
outcomes. They should simply be objective about reviewing the clinical trials,
by removing the bias introduced by PhRMA, and prescribe what is in the best
interest of the patient both medically and financially.
Back to the Caveman Days
February 14, 2008 9:54 PM
Wow,
so you are saying most doctors are greedy. I say some are but not the majority.
If you spent more time banning tobacco and liquor, the main health concerns for
the public, maybe you would not need all those 3-cent pens or $6 pizzas. Maybe
ban all computers--that's why the USA kids and adults are lazy. People like you
have no clue. People today including you and doctors live at "free will."
Do what you want to do to yourself and others, and as long as it is
legal--tough break. Sorry, you lose.
laurenpharm
February 18, 2008 3:09 PM
Mr.
Johnson from PhRMA states: "To us, the evidence is compelling: Physicians
meeting with well-trained company representatives gain crucial knowledge about
side-effect profiles and proper use of medicines." In all my years as a
hospital pharmacy supervisor or director, I don't recall being educated by the
drug rep on the side effects of the drugs they were marketing. The side effects
are downplayed, just as they are downplayed by the industry during clinical
trials and post-marketing periods. Just look at the kind of massive public
outcry that had to occur to get PhRMA and the FDA to issue suicidal ideation
warnings on children and antidepressants.
dadpatel
February 25, 2008 3:48 AM
Let's
not forget politicians and lobbyists while we are on the related matter. The
decisions politicians make with the same type of implied change in behavior has
more far-reaching effects than a doctor's writing an extra prescription for
Viagra.
oldalchemist
May 12, 2008 12:24 PM
In
the last several years while visiting several medical centers, I talked with
many pharma reps. None had any science background but held B.A.'s and MBA's in marketing
or business. These very pleasant folks could only repeat "co.line"
when I asked tech "trick" questions, especially about dominions of
related drugs or locus and ethnicity of clinical trials--forget the math. I am
the recipient of a recent implant about which I have grave doubts, especially
after interface with three company reps.
Millicent Blair
May 12, 2008 6:02 PM
I just gave a presentation at the university I attend. It was on
"Present Day Medicine." As part of the talk, I showed a DVD called Money
Talks and also one
called Side Effects.
It
was on this very subject, and in the film "pharma reps" showed and
talked about methods that were used to influence physicians to use the products
they were representing. Not all physicians know they are influenced (they do
need to find out all about the products represented). However, many of the drug
companies told them only part of the story. (The drug companies often locked
away reports of adverse affects of the new drugs.)
Often
the purpose of introducing a new drug was money alone--in order to be able to
charge more than other, older drugs that did the same thing, although often the
new one caused dangerous side effects that the older drug usually did not have.
All for financial
gain.
Thomas
May 19, 2008 8:05 PM
Insulting?
It's insulting that people of science wouldn't acknowledge the basic law of
business: pharma companies wouldn't dump millions of dollars into these
programs if they didn't work. The idea of doctors as heroic icons that are
immune to the concepts of social marketing is laughable. I should know, I'm
related to a doctor and that person is no better than any of us regular folk.
Sam Rainey
May 19, 2008 10:11 PM
Okay,
so let's ban other forms of marketing and promotional gifts for everyone, not
just doctors--no business meals, no trips to the Super Bowl for clients, etc.
Otherwise,
who are you to single out physicians? You have no right to regulate their
behavior in this way. It's a free country and physicians can act as they like.
regularreader
May 19, 2008 11:34
PM
We
are talking about business and with business there will be profit. Who demands
profit? Share holders. Who are share holders? The "public" (although
the percentage of people who participate in the stock market directly or
indirectly is another question).
Every
individual has the fundamental right to further his business using fair
business practices. A pharma sales rep is as good or as bad as any other
advertising channel. Because in the end, if the doctor cares about his
reputation, he will be careful to prescribe the medicine he thinks is most
effective, irrespective of how many sales reps called on him.
Sometimes
we, the general public, are not aware of what a doctor does before prescribing
a new medicine. Here are some of the things he or she often does:
1. Talks to his/her peers, his/her seniors, and other
personal/professional contacts.
2. Reads about it
3. Attends lectures (yes, paid for by the indsutry), symposiums, etc.
2. Reads about it
3. Attends lectures (yes, paid for by the indsutry), symposiums, etc.
So
you have a choice to either trust him or not. If you are not happy with the
prescription practices of your doctor, you are free to change. That is the
beauty of the system.
Then
there are also insurance companies and pharmacies that replace the prescribed
medicines with equally effective generics, reducing the costs to the consumer.
So if you see the current system as a whole, you will appreciate that it is
continously evolving to benefit the consumer.
daniel
May 20, 2008 6:29 AM
I
worked for Sanofi-Synthelabo {now Sanofi-Aventis} and Sandoz {generic firm of Novartis}
as a medical rep in South Africa. I hated having to bribe my way to get scripts
and orders by giving gifts and dispensing bonuses and cash backs. It is a use
and abuse system where the doctors flock to the latest company offering an
'incentive' and the pharma companies use questionable tactics to get the most
business from the doctors. The doctors and pharma both abuse each other for
what they want. There is no loyalty or ethics where big profits are concerned.
The
saddest thing of all is that the patient always loses out to the corrupt motive
for profit by both the doctor and big pharma. I am no longer in the industry
and I have come to despise it.
Jacob
May 22, 2008 10:14
AM
There
seems to be a common logical theme: If the lunches and trips and perks didn't
influence doctors, then why would Big Pharma spend millions a year on them? If
there were no ROI, then why would the money be spent? Further, if doctors
really cared about their patients and the general public, then wouldn't they
say, "Hey, these drugs are expensive the way it is, let alone with all the
extra expenses of trips and dinners, so please don't spend this extra money on
trying to bribe me, and just help my patients." But they don't, and
instead choose to accept perks and bill like crazy and then point their finger
at insurance companies for the raising cost of health care.
Blame it on others
May 22, 2008 2:06 PM
Surprise.
First we don't want to eat and live healthy. We want more and more
prescriptions. Now pharma companies want to take full advantage of your
laziness. Lift that fat ugly backside of yours, and start living healthy.
You
won't need a doctor, medicine, or pharma companies either.
pat
May 22, 2008 5:07 PM
Ban
all forms drug advertising on TV and nonmedical magazines. Ban drug rep visits
and lunches in doctors' offices. Pharma companies should be allowed to promote
their products in regional meetings. All speakers at the meetings should
disclose the grants they receive from the drug companies. If a drug rep treats
a doctor with a $100 dollar wine and dine, he can influence the doctor's
prescription habits.
KT
June 27, 2008 4:18
PM
I
wonder why we always expect our doctors to be the saints or priests. They are
merely trying to make a living like the rest of us. Ambroise Paré said, "I
dressed the wound, and God healed the patient." If our own bodies lose the
ability to heal from any injury, how can we recover from a major surgery even
with the best medicine?
Insider
June 30, 2008 10:02
PM
Just
ask Pfizer how much they will pay a doctor to talk to other doctors and
side-step the safety issues. Not the average, but the pay for the 10% of their
stable that does 90% of the talks. The kind of money they are willing to put in
their "experts" pockets to give presentations shows how corrupt the
system is.
IndustryInsider
July 3, 2008 8:51 AM
You
can't have it both ways, people. On the one hand, you love the pharmaceutical
industry for its innovation and ability to develop cures and prevention of
disease. All of which, by the way, costs billions of dollars in R&D. Yet,
nobody expects to have to pay for it. The price of pharmaceuticals is based on
the value the drug provides and by profit required to drive future innovation,
not the cost of goods (the cost to manufacture the pill). People don't
understand this concept. They think because a pill contains 10 cents of
ingredients, that the price for the prescription should be low. The reality is
that for every one drug that makes it to the pharmacy counter, there are 1,000
drugs that never even make it out of clinical trials. All of this costs money.
Consumers are paying for the price of development of that drug, and the
development of all future drugs that may or may not ever get past the test tube
phase of development. If a drug company is not allowed to generate profit to
put back into R&D, we may as well kiss this industry good bye. What is a
fair profit? That question could be asked of many industries (oil, consumer
electronics, furniture, etc.).
mockbadoc
July 16, 2008 1:02 AM
I
think that it is irresponsible and misleading to frame the question in this
way. Many physicians are asked to speak to groups about particular medications
or products, and are paid a fee for their time. This is hardly a
"gift." I myself have not, but I would not be resistant to giving a
lecture about a medication or procedure I believe in.
It
was this same sort of irresponsible alarmism that caused patients to eschew
Celebrex in favor of older and more dangerous medications, to their ultimate
detriment. This shameless, self-serving, and dangerous baiting of those who
depend on others to vet their medical information is the worst kind of sham
journalism, it is dangerous, and it must end. As far as I can tell, this
endless suspicion-mongering has never saved a single human life. There are
plenty of real stories to be told--how smoking cessation programs save lives,
how the new "evidence-based medicine" journalism rewards negative and
overblown side-effect reports more than actual scientific data--but they are
not much fun to write or to read.
Want
to practice medicine? Do it. I promise you it is not what you believe it to be.
Otherwise, let those of us who have taken an oath to help and not to harm do
our job in peace without the constant din of negativism and suspicion that has
infected our patients without cause or positive effect.
John R. Polito
July 29, 2008 9:07
AM
I
just read Pfizer's response to BusinessWeek's "Doctors Under the
Influence" article in which Pfizer asserts that the article "relies
on innuendo and distortion to support empty charges of lack of disclosure about
interactions between pharmaceutical companies and physicians," is
"odd and troubling," that there "is no failure of transparency
here, only a cynical attempt by your magazine to portray it as such....By
implying that any paid relationship with an expert is inappropriate, you betray
a fundamental lack of understanding of that process....Instead, your magazine
published a story reflecting a pronounced anti-industry, anti-physician bias.
Your readers deserve better."
First,
Jonathan Foulds, PhD, is not a physician. Yes, he has been involved in
cessation research but also chose to serve as a member of Pfizer's speakers'
bureau, as a paid sales agent for Pfizer. Pfizer knows that Professor Foulds
has written a number of online blogs supporting Chantix without advising
readers that Pfizer selected him to assist in marketing Chantix.
Pfizer
should not need to await federal legislation to demand total financial
transparency and disclosure by its paid agents when writing in support of its
products. If Pfizer isn't outraged by the non-disclosure in Professor Foulds'
Chantix blogs, it should be.
John R. Polito
Nicotine Cessation Educator
Ell
January 17, 2009
10:18 AM
I
was a pharmaceutical rep. Not only did these "hungry for freebies"
S.O.B.s accept the gifts, dinners, grants, trips, tickets, and everything else
they could get their greedy hands on, but they were rude and abusive to me as
well. Pathetic.
Ashton
April 12, 2009 11:14
PM
I
think doctors are wise enough to recognize the obvious reason a pharmaceutical
company's giving them health freebies or free stuff.
Gracie
June 28, 2009 6:19
AM
Health
care it shouldn't be a business. Physicians shouldn't be "selling"
pills to patients just because they have a nice dinner after or a relaxing
vacation in Hawaii paid by the "gealth" corporations. It's our health
and our lives. It's a simple and basic ethical behavior. If they want
additional money, just go out and work in Macy's for a salary and commission.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.